vs

Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and QUICKLOGIC Corp (QUIK). Click either name above to swap in a different company.

Arbutus Biopharma Corp is the larger business by last-quarter revenue ($10.7M vs $5.7M, roughly 1.9× QUICKLOGIC Corp). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs -5.4%, a 28.9% gap on every dollar of revenue. On growth, Arbutus Biopharma Corp posted the faster year-over-year revenue change (522.2% vs -24.1%). Over the past eight quarters, QUICKLOGIC Corp's revenue compounded faster (17.2% CAGR vs -13.2%).

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.

QuickLogic Corp is a fabless semiconductor company developing low-power customizable FPGAs, embedded FPGA IP, and edge sensor processing solutions. Its offerings serve global wearables, IoT, mobile electronics, and industrial markets, enabling energy-efficient low-latency on-device processing for edge AI and sensing use cases.

ABUS vs QUIK — Head-to-Head

Bigger by revenue
ABUS
ABUS
1.9× larger
ABUS
$10.7M
$5.7M
QUIK
Growing faster (revenue YoY)
ABUS
ABUS
+546.3% gap
ABUS
522.2%
-24.1%
QUIK
Higher net margin
ABUS
ABUS
28.9% more per $
ABUS
23.5%
-5.4%
QUIK
Faster 2-yr revenue CAGR
QUIK
QUIK
Annualised
QUIK
17.2%
-13.2%
ABUS

Income Statement — Q2 FY2025 vs Q4 FY2024

Metric
ABUS
ABUS
QUIK
QUIK
Revenue
$10.7M
$5.7M
Net Profit
$2.5M
$-305.0K
Gross Margin
62.7%
Operating Margin
13.9%
2.6%
Net Margin
23.5%
-5.4%
Revenue YoY
522.2%
-24.1%
Net Profit YoY
112.7%
-114.9%
EPS (diluted)
$0.01
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABUS
ABUS
QUIK
QUIK
Q2 25
$10.7M
Q4 24
$5.7M
Q3 24
$4.2M
Q2 24
$4.1M
Q1 24
$5.7M
Q4 23
$2.1M
$6.7M
Q3 23
$4.7M
$2.9M
Q2 23
$4.7M
$4.1M
Net Profit
ABUS
ABUS
QUIK
QUIK
Q2 25
$2.5M
Q4 24
$-305.0K
Q3 24
$-2.1M
Q2 24
$-1.6M
Q1 24
$108.0K
Q4 23
$1.2M
Q3 23
$-20.1M
$-2.3M
Q2 23
$-17.1M
$-1.2M
Gross Margin
ABUS
ABUS
QUIK
QUIK
Q2 25
Q4 24
62.7%
Q3 24
59.1%
Q2 24
54.7%
Q1 24
67.1%
Q4 23
76.9%
Q3 23
41.2%
Q2 23
57.8%
Operating Margin
ABUS
ABUS
QUIK
QUIK
Q2 25
13.9%
Q4 24
2.6%
Q3 24
-38.1%
Q2 24
-29.3%
Q1 24
2.3%
Q4 23
-967.2%
19.2%
Q3 23
-462.8%
-76.2%
Q2 23
-395.3%
-26.6%
Net Margin
ABUS
ABUS
QUIK
QUIK
Q2 25
23.5%
Q4 24
-5.4%
Q3 24
-49.8%
Q2 24
-37.8%
Q1 24
1.9%
Q4 23
17.9%
Q3 23
-431.6%
-77.7%
Q2 23
-367.5%
-29.7%
EPS (diluted)
ABUS
ABUS
QUIK
QUIK
Q2 25
$0.01
Q4 24
$-0.02
Q3 24
$-0.14
Q2 24
$-0.11
Q1 24
$0.01
Q4 23
$-0.12
$0.08
Q3 23
$-0.12
$-0.17
Q2 23
$-0.10
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABUS
ABUS
QUIK
QUIK
Cash + ST InvestmentsLiquidity on hand
$37.4M
Total DebtLower is stronger
$0
$3.1M
Stockholders' EquityBook value
$83.0M
$24.9M
Total Assets
$103.3M
$51.9M
Debt / EquityLower = less leverage
0.00×
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABUS
ABUS
QUIK
QUIK
Q2 25
$37.4M
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
$126.0M
Q3 23
$17.5M
Q2 23
$27.2M
Total Debt
ABUS
ABUS
QUIK
QUIK
Q2 25
$0
Q4 24
$3.1M
Q3 24
$3.4M
Q2 24
$1.2M
Q1 24
$1.4M
Q4 23
$0
Q3 23
$0
Q2 23
$0
Stockholders' Equity
ABUS
ABUS
QUIK
QUIK
Q2 25
$83.0M
Q4 24
$24.9M
Q3 24
$20.9M
Q2 24
$21.8M
Q1 24
$22.2M
Q4 23
$106.0M
$14.0M
Q3 23
$119.3M
$12.2M
Q2 23
$134.7M
$13.7M
Total Assets
ABUS
ABUS
QUIK
QUIK
Q2 25
$103.3M
Q4 24
$51.9M
Q3 24
$49.7M
Q2 24
$47.5M
Q1 24
$51.9M
Q4 23
$144.4M
$36.5M
Q3 23
$158.6M
$34.4M
Q2 23
$176.8M
$34.7M
Debt / Equity
ABUS
ABUS
QUIK
QUIK
Q2 25
0.00×
Q4 24
0.12×
Q3 24
0.16×
Q2 24
0.06×
Q1 24
0.06×
Q4 23
0.00×
Q3 23
0.00×
Q2 23
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABUS
ABUS
QUIK
QUIK
Operating Cash FlowLast quarter
$-15.7M
$116.0K
Free Cash FlowOCF − Capex
$-1.2M
FCF MarginFCF / Revenue
-20.6%
Capex IntensityCapex / Revenue
0.0%
22.6%
Cash ConversionOCF / Net Profit
-6.24×
TTM Free Cash FlowTrailing 4 quarters
$-5.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABUS
ABUS
QUIK
QUIK
Q2 25
$-15.7M
Q4 24
$116.0K
Q3 24
$-16.0K
Q2 24
$-220.0K
Q1 24
$147.0K
Q4 23
$-17.3M
$130.0K
Q3 23
$-21.8M
$38.0K
Q2 23
$-19.6M
$-359.0K
Free Cash Flow
ABUS
ABUS
QUIK
QUIK
Q2 25
Q4 24
$-1.2M
Q3 24
$-83.0K
Q2 24
$-4.2M
Q1 24
$62.0K
Q4 23
$-1.5M
Q3 23
$-21.8M
$-47.0K
Q2 23
$-20.4M
$-361.0K
FCF Margin
ABUS
ABUS
QUIK
QUIK
Q2 25
Q4 24
-20.6%
Q3 24
-2.0%
Q2 24
-102.2%
Q1 24
1.1%
Q4 23
-22.7%
Q3 23
-468.4%
-1.6%
Q2 23
-439.0%
-8.7%
Capex Intensity
ABUS
ABUS
QUIK
QUIK
Q2 25
0.0%
Q4 24
22.6%
Q3 24
1.6%
Q2 24
96.9%
Q1 24
1.5%
Q4 23
0.0%
24.7%
Q3 23
0.7%
2.9%
Q2 23
18.5%
0.0%
Cash Conversion
ABUS
ABUS
QUIK
QUIK
Q2 25
-6.24×
Q4 24
Q3 24
Q2 24
Q1 24
1.36×
Q4 23
0.11×
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABUS
ABUS

Segment breakdown not available.

QUIK
QUIK

North America$3.0M53%
Other$2.7M47%

Related Comparisons